Glooko
Glooko is a universal diabetes management platform designed to enhance health outcomes for individuals with diabetes and their healthcare teams. The platform integrates with a wide range of diabetes devices and fitness trackers, allowing for the collection of vital patient data, including glucose levels, medication usage, blood pressure, and dietary information. By providing personalized and timely insights, Glooko supports remote patient monitoring and facilitates interventions aimed at improving patient care. The platform is utilized in over 7,000 clinical locations and is trusted by more than 1.5 million users across 23 countries and 15 languages. Through its comprehensive data synchronization and analytics capabilities, Glooko aims to drive behavior change and optimize diabetes management.
Diasend simplifies life for people with diabetes and facilitates the work of their health care providers by optimizing diabetes data management. The company’s comprehensive and market leading solution involves transmitting, storing and analyzing data from more than 140 different glucose meters, insulin pumps, CGM systems and leading activity trackers – allowing patients and caregivers to easily access the exact same information. Diasend’s products and services, all FDA approved and CE marked, are currently used in 23 countries. Headquarters are located in Gothenburg, Sweden – with subsidiaries in Chicago and London.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.